---
title: Multiple Vulnerabilities in Mira Hormone Monitor and Android App
slug: 2026-08-mira-hormone-monitor-vulns
description: Multiple critical vulnerabilities in Quanovate Tech Inc. Mira Hormone Monitor firmware and Android application enable unauthenticated remote access, health data tampering, and credential theft via BLE and cloud-based attack vectors.
date: "2026-08-11T17:37:00Z"
type: advisory
types:
  - advisory
severities:
  - critical
tags:
  - medical-device
  - vulnerability
  - ics
  - health-data
vendors:
  - Quanovate Tech Inc.
products:
  - Mira Hormone Monitor
  - Mira Android App
mitre_ttps:
  - tactic_id: TA0001
    tactic_name: Initial Access
    technique_id: T1566
    technique_name: Phishing
    evidence: The Mira Android companion app identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only.
    confidence_band: high
  - tactic_id: TA0006
    tactic_name: Credential Access
    technique_id: T1552.001
    technique_name: Credentials in Files
    evidence: The distributed Mira Android APK allows an attacker read/write access to reproductive health profiles from internet connected hosts, which could result in forgery, deletion, or destruction of health information.
    confidence_band: med
references:
  - https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01
  - https://www.cve.org/CVERecord?id=CVE-2026-66875
  - https://www.cve.org/CVERecord?id=CVE-2026-66098
  - https://www.cve.org/CVERecord?id=CVE-2026-67558
  - https://www.cve.org/CVERecord?id=CVE-2026-67568
action_plan:
  priority: immediate_escalation
  owners:
    - SOC
    - IT Operations
  immediate_actions:
    - action: Update Mira Android App to 4.5.18 or higher and monitor for firmware updates.
      owner: IT Operations
      due: 24h
      evidence: Remediation guidance provided in CISA advisory.
---

Researchers have identified eight critical vulnerabilities (CVE-2026-66875, CVE-2026-66098, CVE-2026-67558, CVE-2026-67568, CVE-2026-68067, CVE-2026-66340, CVE-2026-64934, CVE-2026-66832) within the Mira Hormone Monitor firmware version 1.7.1.47 and the associated Mira Android application version 4.5.15.4. The vulnerabilities stem from a lack of secure authentication for critical device functions, use of hard-coded credentials, and improper validation of Bluetooth Low Energy (BLE) peripheral identity.

Defenders should note that these flaws allow unauthenticated attackers within BLE range (10-30 meters) to rebind devices, intercept cleartext hormone data, and disrupt fertility monitoring services. Furthermore, cloud-facing vulnerabilities in the associated Android APK permit unauthorized access to reproductive health profiles, potentially leading to the destruction or forgery of sensitive clinical data. The breadth of these flaws, particularly those enabling remote cloud-based exploitation and local BLE spoofing, presents a significant risk to the privacy and integrity of user healthcare information.

## Impact

Successful exploitation allows for unauthorized access to sensitive reproductive health profiles, the ability to manipulate historical clinical trends, disclosure of session tokens, and complete loss of account control. These vulnerabilities affect the Healthcare and Public Health sector worldwide, directly impacting user safety and the reliability of fertility monitoring workflows.

## Recommendation

- Immediately update the Mira Android application to version 4.5.18 or higher.
- Ensure the Mira Monitor hardware firmware is updated to version 01.07.01.53, which is triggered automatically via the updated Android application.
- Review network access logs for unusual patterns of interaction with Mira cloud API endpoints if the application was utilized in a high-threat environment.
- Monitor for anomalous BLE advertisement names that attempt to masquerade as legitimate Mira devices to facilitate peripheral spoofing.
